Methods for reducing circulating glucose levels

Details Methods for reducing circulating glucose levels Methods for reducing circulating glucose levels

2011-01-25

2011-01-25

Tate, Christopher R. (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Reexamination Certificate

active

07875300

ABSTRACT:
The invention relates to methods of reducing circulating glucose levels with compositions obtained from botanical sources. More specifically, the invention relates to methods of treating individuals whom wish to reduce their circulating glucose levels, particularly individuals having elevated circulating glucose levels, with an extract product ofAframomum melegueta.

REFERENCES:
patent: 5879682 (1999-03-01), Allas et al.
patent: 2005/0058728 (2005-03-01), Randolph et al.
patent: 2005/0260290 (2005-11-01), Raskin et al.
patent: 2006/0188590 (2006-08-01), Ono
patent: 2006-045210 (2006-02-01), None
patent: 2006-249064 (2006-09-01), None
patent: WO-2005/025586 (2005-03-01), None
patent: WO-2005/074959 (2005-08-01), None
Sekiya et al. BioFactors. 2004. vol. 22, No. 1-4, pp. 153-156.
Kadnur et al. Indian J. Exp. Biol. Dec. 2005. vol. 43, No. 12, pp. 1161-1164, ESBIOBASE Abstract enclosed.
Saeed et al. Intl. J. Biol. Biotechnol. Jul. 2006. vol. 3, No. 3, pp. 519-526, BIOSIS Abstract enclosed.
Kato et al. J. Agric. Food Chem. 2006. vol. 54, No. 18, pp. 6640-6644.
Shishodia et al. Annals New York Acad. Sciences. 2005. pp. 206-217, editor Kotwal, GJ, BIOSIS Abstract enclosed.
Agricultural Research Service, “Phytochemical and Ethnobotanical Databases,” Aframomum meleguetaK., Schum.—Zingiberaceae Retrieved from the Internet on Apr. 5, 2004: <URL: http://www.ars-grin.gov:8080
pgspub/xsql/duke/plantdisp.xsql?taxon=2367>.
Baynes, “Role of Oxidative Stress in Development of Complications in Diabetes,”Diabetes, 40:405-412 (1991).
Chung et al., “Antioxidative and Antitumbr Promoting Effects of [6]-paradol and its Homologs,”Mutat. Res., 496:199-206 (2001).
Enyikwola, “Effects of Guinea Pepper (Aframomum melegueta) on Gastric Acid Secretion in Albino Rats,”Int. J. Pharmacog., 32(1):37-43 (1994).
Giugliano etal., “Oxidative Stress and Diabetic Vascular Complications,”Diabetes Care, 19(3):257-267 (1996).
Grundy et al., “Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition,”Circulation, 109:433-438 (2004).
Guh et al., “Antiplatelet Effect of Gingerol Isolated fromZingiber officinale,” J. Pharm. Pharmacol., 47:329-332 (1995).
ITIS Report, “Aframomum meleguetaSchumann, Taxonomic Serial No. 506501,” Retrieved from the Internet on Feb. 22, 2007: <URL: www.itis.gov/servlet/SingleRpt/SingleRpt>.
Iwu et al., “New Antimicrobials of Plant Origin,”Perspectives on New Crops and New Uses, pp. 457-462, J. Janick (ed.), ASHS Press, Alexandria, VA (1999).
Iwu, African Ethnomedicine, Printed by CECTA (Nigeria) Limited, Enugu, Nigeria, Table of Contents, pp. 34-37, 62-65, and 70-71 (1986).
Iwu, Handbook of African Medicinal Plants, CRC Press, Inc., Boca Raton, Florida, Table of Contents, pp. 9-71 and 108-109 (1993).
Konning et al., “Antimicrobial Activity of Some Medicinal Plants from Ghana,”Fitoterapia, 75:65-67 (2004).
Koo et al., “Gingerols and Related Analogues Inhibit Arachidonic Acid-induced Human Platelet Serotonin Release and Aggregation,”Thromb. Res., 103:387-397 (2001).
Nurtjahja et al., “The Anti-platelet Aggregating Activity of Natural Ginger Constituents and Synthetic Analogues,”3rdCollege of Health Sciences and Medical Foundation Research Conference: From Cell to Society 3, (Sep. 2002).
Nurtjahja-Tjendraputra et al., “Effective Anti-platelet and COX-1 Enzyme Inhibitors from Pungent Constituents of Ginger,”Thromb. Res., 111:259-265 (2003).
Rafatullah et al., “Gastric and Duodenal Antiulcer and Cytoprotective Effects ofAframomum meleguetain Rats,”Int. J. Pharmacog., 33(4):311-316 (1995).
Suekawa et al., “Pharmacological Studies on Ginger. I. Pharmacological Actions of Pungent Constituents, (6)-Gingerol and (6)-Shogaol,”J. Pharm. Dyn., 7:836-848 (1984).
Surh, “Anti-tumor Promoting Potential of Selected Spice Ingredients with Antioxidative and Anti-inflammatory Activities: A Short Review,”Food and Chem. Toxicol., 40:1091-1097 (2002).
Tackie et al., “Hydroxyphenylalkanones FromAmomum melegueta,” Phytochemistry, 14:853-854 (1975).
Tjendraputra et al., “Effect of Ginger Constituents and Synthetic Analogues on Cyclooxygenase-2 Enzyme in Intact Cells,”Bioorg. Chem., 29:156-163 (2001).
U.S. Department of Agriculture, Natural Resources Conservation Service, Plants Classification Report, “Classification for Kingdom Plantae Down to SpeciesAframomum melegueta,” Retrieved from the Internet on Apr. 5, 2004: <URL: http://plants.usda.gov/classification/output—report.cgi?3/S/AFME/u/140/+31>.
Umukoro et al., “Effects ofAframomum melegutaSeed Extract on Thermal Pain and Carrageenin-Induced Oedema,”Nig. Ot J. Hosp. Med., 11(1-4):33-35 (2001).
Al-Amin et al., “Anti-Diabetic and Hypolipidaemic Properties of Ginger (Zingiber officinale) in Streptozotocin-Induced Diabetic Rats,”British J. Nutri., 96:660-666 (2006).
International Search Report for PCT/US2007/085369, dated May 22, 2008.
Written Opinion of the International Search Authority for PCT/US2007/085369, dated May 22, 2008.
International Preliminary Report on Patentability for PCT/US2007/085369, dated Jun. 4, 2009.

Affiliated with

Also associated with

Rating

Methods for reducing circulating glucose levels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for reducing circulating glucose levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing circulating glucose levels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2665839